Neurosoft Bioelectronics

Neurosoft Bioelectronics

Private
GenevaHealthcare & Life Scienceshttps://www.neurosoft-bio.com/

Last Round

Seed

May 20, 2026

Total Funding Raised

$15M

Momentum Score

50 /100

Company Overview

Neurosoft Bioelectronics is a medtech company that develops and manufactures soft, elastic, and minimally invasive brain-computer interfaces (BCIs) and neural implants to monitor, treat, and restore neurological functions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Sensors, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Data as a Service, Government Contracts

AI Layer

Application

Keywords

brain-computer interfaceBCIsoft electrodesimplantable electrodesneurotechnologybrain implantsneural interfaceneuromodulationepilepsy treatmentminimally invasiveneural recordingtinnitus treatmentsubdural electrodesmedical devicesneural data platformneural foundation model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neurosoft Bioelectronics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Neurosoft Bioelectronics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedMay 20, 2026
SeedMay 20, 2024

Key People

Founding team and executive leadership

Florian Fallegger

Chief Scientific Officer And Co-Founder

Founding Team

Ludovic Serex

COO And Co-Founder

Founding Team

Nicolas Vachicouras

CEO & Co-Founder

Founding Team

Neurosoft Bioelectronics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    $8M round led by Skybound Venture Capital

  • Feb 16, 2026

    Grew 58% QoQ, from 12 to 19 employees.

Neurosoft Bioelectronics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neurosoft Bioelectronics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neurosoft Bioelectronics's valuation, stock price, and market status.

Firmographic Details

HeadquartersGeneva
Employee Range19
Year Founded2019
Last FundingMay 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.